Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Solidus Investment

Profile and portfolio

Parent JW Pharmaceutical

Solidus Investment is the corporate venture arm of JW Pharmaceutical, a pharmaceutical and biotech company. Sectors it names: biotech and life sciences, medical devices.

Every figure links to its source

Where it invests

Geography

Investment regionsS2S1

Key facts

FactValueStatusSource
Parent companyJW PharmaceuticalSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1

Portfolio

Public sources name 10 portfolio companies.S3

Every company on the Solidus Investment list

10 companies, as named in the sources cited.S3 Read the firm's list.

  • Alteogen (알테오젠)
  • ARIbio (아리바이오)
  • Canaf Therapeutics (카나프테라퓨틱스)
  • CAPS Bio (캅스바이오)
  • GenomicTree (지노믹트리)
  • IM Biologics (아이엠바이오로직스)
  • Neurophet (뉴로핏)
  • Olix (올릭스)
  • Tium Bio (티움바이오)
  • Ubix Therapeutics (유빅스테라퓨틱스)

Sources

  1. S1Yonhap: JW Pharmaceutical acquires affiliate Solidus Investment shares for KRW 30.7bn (2026-09-29)Press
  2. S2The Bio News: JW Pharmaceutical acquires Solidus Investment to strengthen open innovationPress
  3. S3Edaily: Solidus Investment CEO Kim Jung-hyun on bio venturesPress

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Solidus Investment or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.